Emerald Health Pharmaceuticals has filed a Tier II Reg A+ preliminary prospectus seeking to raise $50 million by selling up to 10 million shares at $5 per share. The...

Emerald Health Announces $15 Million Prospectus Sale; Concurrent Secondary Sale VICTORIA, British Columbia, Jan. 03, 2018 (GLOBE NEWSWIRE) — Emerald Health Therapeutics, Inc. (TSXV: EMH) (OTCQX: EMHTF) (“Emerald” or the...